On July 2, SELLAS Life Sciences Group rose 8.67% in regular trading, trading at $14.47 USD/share, with turnover of $31.87 million.
Within the Biotechnology sector where SELLAS Life Sciences Group belongs, among individual stocks, Propanc Biopharma up 38.89%, Moderna up 10.73%, Abivax S.A. up 8.79%, Vertex Pharmaceuticals up 3.21%, AbbVie up 1.43%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)